Erratum: A meta-analysis and systematic review of randomized controlled trials with degarelix versus gonadotropin-releasing hormone agonists for advanced prostate cancer: Erratum.
出版信息
Medicine (Baltimore). 2016 Dec 9;95(49):e5671. doi: 10.1097/MD.0000000000005671. eCollection 2016 Dec.
